(MTX) Minerals Technologies - NYSE
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 2.422m USD | Total Return: 44.1% in 12m
Avg Turnover: 11.7M
EPS Trend: 55.0%
Qual. Beats: 1
Rev. Trend: -75.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Minerals Technologies Inc. (NYSE: MTX) is a global resource-based company focused on the development and production of mineral and mineral-based specialty products. The firm operates through two primary segments: Consumer & Specialties, which provides additives for paper, packaging, and household products; and Engineered Solutions, which focuses on high-temperature refractory materials and environmental infrastructure technologies.
The company utilizes a vertically integrated business model, often co-locating its precipitated calcium carbonate (PCC) plants directly at customer paper mills to reduce logistics costs and ensure a continuous supply chain. As a participant in the specialty chemicals sector, the business is driven by industrial demand for functional fillers and high-performance minerals that enhance the structural integrity of automotive, construction, and water purification systems.
Investors looking for deeper fundamental insights may find it useful to evaluate the companys historical performance metrics on ValueRay. The firm maintains a diverse geographic footprint across North America, Europe, and Asia, mitigating localized economic downturns through broad market exposure.
- Precipitated calcium carbonate demand from paper and packaging industries drives top-line growth
- Raw material and energy cost fluctuations impact margins in high-temperature technology
- Global infrastructure spending and municipal projects dictate environmental and infrastructure segment revenue
- Consumer discretionary spending levels influence specialty mineral sales in household and pet care
| Net Income: 161.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.92 > 1.0 |
| NWC/Revenue: 28.77% < 20% (prev 25.84%; Δ 2.93% < -1%) |
| CFO/TA 0.07 > 3% & CFO 230.2m > Net Income 161.7m |
| Net Debt (644.9m) to EBITDA (368.4m): 1.75 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.0m) vs 12m ago -2.82% < -2% |
| Gross Margin: 24.89% > 18% (prev 25.60%; Δ -0.71% > 0.5%) |
| Asset Turnover: 61.97% > 50% (prev 61.03%; Δ 0.94% > 0%) |
| Interest Coverage Ratio: 4.88 > 6 (EBIT TTM 268.0m / Interest Expense TTM 54.9m) |
| A: 0.18 (Total Current Assets 1.16b - Total Current Liabilities 543.4m) / Total Assets 3.47b |
| B: 0.73 (Retained Earnings 2.51b / Total Assets 3.47b) |
| C: 0.08 (EBIT TTM 268.0m / Avg Total Assets 3.43b) |
| D: 1.01 (Book Value of Equity 1.73b / Total Liabilities 1.70b) |
| Altman-Z'' = 5.11 = AAA |
| DSRI: 0.99 (Receivables 412.7m/405.9m, Revenue 2.13b/2.08b) |
| GMI: 1.03 (GM 25.60% / 24.89%) |
| AQI: 0.99 (AQ_t 0.37 / AQ_t-1 0.37) |
| SGI: 1.03 (Revenue 2.13b / 2.08b) |
| TATA: -0.02 (NI 161.7m - CFO 230.2m) / TA 3.47b) |
| Beneish M = -3.00 (Cap -4..+1) = A |
As of June 15, 2026, the stock is trading at USD 78.12 with a total of 92,323 shares traded.
Over the past week, the price has changed by +3.02%,
over one month by -2.98%,
over three months by +12.79% and
over the past year by +44.11%.
Minerals Technologies has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy MTX.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94.3 | 20.6% |
P/E Trailing = 15.3477
P/E Forward = 12.1951
P/S = 1.1385
P/B = 1.3872
P/EG = 2.2199
Revenue TTM = 2.13b USD
EBIT TTM = 268.0m USD
EBITDA TTM = 368.4m USD
Long Term Debt = 954.0m USD (from longTermDebt, last quarter)
Short Term Debt = 12.2m USD (from shortTermDebt, last quarter)
Debt = 966.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.9m USD (calculated: Debt 966.2m - CCE 321.3m)
Enterprise Value = 3.07b USD (2.42b + Debt 966.2m - CCE 321.3m)
Interest Coverage Ratio = 4.88 (Ebit TTM 268.0m / Interest Expense TTM 54.9m)
EV/FCF = 25.93x (Enterprise Value 3.07b / FCF TTM 118.3m)
FCF Yield = 3.86% (FCF TTM 118.3m / Enterprise Value 3.07b)
FCF Margin = 5.56% (FCF TTM 118.3m / Revenue TTM 2.13b)
Net Margin = 7.60% (Net Income TTM 161.7m / Revenue TTM 2.13b)
Gross Margin = 24.89% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.60b) / Revenue TTM)
Gross Margin QoQ = 23.97% (prev 23.97%)
Tobins Q-Ratio = 0.89 (Enterprise Value 3.07b / Total Assets 3.47b)
Interest Expense / Debt = 5.68% (Interest Expense 54.9m / Debt 966.2m)
Taxrate = 22.01% (46.9m / 213.1m)
NOPAT = 209.0m (EBIT 268.0m * (1 - 22.01%))
Current Ratio = 2.13 (Total Current Assets 1.16b / Total Current Liabilities 543.4m)
Debt / Equity = 0.56 (Debt 966.2m / totalStockholderEquity, last quarter 1.73b)
Debt / EBITDA = 1.75 (Net Debt 644.9m / EBITDA 368.4m)
Debt / FCF = 5.45 (Net Debt 644.9m / FCF TTM 118.3m)
Total Stockholder Equity = 1.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.71% (Net Income 161.7m / Total Assets 3.47b)
RoE = 9.55% (Net Income TTM 161.7m / Total Stockholder Equity 1.69b)
RoCE = 10.13% (EBIT 268.0m / Capital Employed (Equity 1.69b + L.T.Debt 954.0m))
RoIC = 7.39% (NOPAT 209.0m / Invested Capital 2.83b)
WACC = 7.39% (E(2.42b)/V(3.39b) * Re(8.57%) + D(966.2m)/V(3.39b) * Rd(5.68%) * (1-Tc(0.22)))
Discount Rate = 8.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.75 | Cagr: -2.08%
[DCF] Terminal Value 77.97% ; FCFF base≈104.9m ; Y1≈120.3m ; Y5≈177.0m
[DCF] Fair Price = 65.09 (EV 2.66b - Net Debt 644.9m = Equity 2.02b / Shares 31.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 54.98 | EPS CAGR: 6.14% | SUE: 1.26 | # QB: 1
Revenue Correlation: -75.74 | Revenue CAGR: -1.52% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.63 | Chg30d=-0.15% | Revisions=-50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.74 | Chg30d=-0.29% | Revisions=+14% | Analysts=4
EPS current Year (2026-12-31): EPS=6.22 | Chg30d=-0.20% | Revisions=+14% | GrowthEPS=+12.6% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=7.13 | Chg30d=+0.00% | Revisions=+43% | GrowthEPS=+14.8% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: -50%